Related Experiment Video
Updated: Jan 23, 2026

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity
Published on: April 11, 2019
Autoreactive T-Lymphocytes in Inflammatory Skin Diseases
Wolf-Henning Boehncke1,2, Nicolo Costantino Brembilla1
1Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Understanding autoimmune diseases requires identifying autoantigens and adaptive immune responses. Characterizing autoreactive T-lymphocytes, including resident memory T-lymphocytes (TRM), is crucial for developing targeted therapies and restoring immune tolerance.
Area of Science:
- Immunology
- Dermatology
- Autoimmunity
Background:
- Autoimmune diseases are defined by autoantigens and adaptive immune responses.
- Recent advancements are expanding the list of autoimmune dermatoses.
- The role of autoreactive T-lymphocytes varies across autoimmune conditions.
Purpose of the Study:
- To explore the diverse roles of autoreactive T-lymphocytes in various autoimmune diseases.
- To highlight the significance of resident memory T-lymphocytes (TRM) in disease relapse.
- To discuss the therapeutic potential of targeting TRM for durable autoimmune disease management.
Main Methods:
- Review of current literature on autoimmune dermatoses.
- Analysis of the functional roles of autoreactive T-lymphocytes (effector vs. helper).
- Examination of the contribution of TRM to disease pathogenesis and relapse.
Main Results:
- Autoreactive T-lymphocytes can act as direct effectors or help B-cells produce autoantibodies.
- Atopic dermatitis exhibits characteristics of both T-lymphocyte roles.
- Psoriasis may include autoimmune subtypes due to identified autoantigens.
- TRM explain site-specific disease relapse after treatment.
Conclusions:
- In-depth characterization of autoreactive T-lymphocytes is vital for advancing autoimmune disease therapy.
- Targeting TRM offers a promising strategy for achieving durable treatment responses.
- Research on TRM and related pathways (JAK3, IL-15) moves closer to restoring immune tolerance.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

